POST Online Media Lite Edition


Roche NimbleGen announces Frank Pitzer as new CEO

Staff writer |
Madison, Wi., USA - March 25, 2010, Madison, Wi., USA - Roche NimbleGen, a provider of microarray tools for genetic discovery and analysis, announced that Frank Pitzer has been appointed as CEO.

Article continues below

Dr. Pitzer most recently served as Head of Divisional Quality and Regulatory Affairs reporting directly to the CEO of Roche Diagnostics and was also an active member of the Diagnostics Executive Committee (DEC).


What to read next

AuraSense Therapeutics names CFO
Golar names Sir Frank Chapman chairman
RainDance Technologies appoints John Luckey as VP